No 6, 2005
Current Concerns
P.O. box 223
CH-8044 Zurich
+41-44-350 65 50
Current Concerns - The monthly journal for independent thought, ethical standards and moral responsibility - English Edition of Zeit-Fragen
No 6, 2005
31 Jul 2010, 12:19 AM
current issue
archive

Tamiflu – a Worthless Drug

by F. William Engdahl, Germany

“Gilead is fortunate to have had Don Rumsfeld as a stalwart board member since the company’s earliest days, and we are very pleased that he has accepted the Chairmanship,” Dr. Riordan said. “He has played an important role in helping to build and steer the company. His broad experience in leadership positions in both industry and government will serve us well as Gilead continues to build its commercial presence.”

Press release by Gilead Sciences Inc., 1997

Is Avian Flu Another Pentagon Hoax?

Against all scientific prudence and procedure the world population is being whipped up by irresponsible public health officials from WHO to the United States Centers for Disease Control about the imminent danger that a malicious viral strain might spread from infected birds, primarily in Vietnam and other Asian centers, to contaminate the entire human species in pandemic proportions.

The only medicine we are told which reduce the symptoms of general or seasonal influenza and “possibly” might reduce symptoms also of Avian Flu, is a drug called Tamiflu. Today the giant Swiss pharmaceutical firm, Roche, holds the sole license to manufacture Tamiflu. Due to the media panic, the order books at Roche today are fuilled to overflowing.

What is not so widely known is that Tamiflu was developed and patented by a California biotech firm, Gilead Sciences Inc., a NASDAQ (GILD) listed stock company which prefers to maintain a low profile in the current rush to Tamiflu. That might be because of who is tied to Gilead. In 1997, before he became US Secretary of Defense, Donald H. Rumsfeld was named Chairman of the Board of Gilead Sciences, where he remained until early 2001 when he 
became Defense Secretary. Rumsfeld had been on the board of Gilead since 1988 according to a January 3 1997 company press release.

An as-yet-unconfirmed report is that Rumsfeld while Secretary of Defense also purchased an additional stock in his former company, Gilead Sciences worth $18 million making him one of its largest if not the largest stock owners. He stands to make a fortune on royalties as a panicked world population scrambles to buy a drug worthless in curing effects of alleged Avian Flu. The model suggests the parallel to the brazen corruption of Halliburton Corporation whose former CEO is Vice President Dick Cheney. Cheney’s company has so far gotten billions worth of US construction contracts in Iraq and elsewhere. Coincidence that Cheney’s closest political friend is Defense Secretary and Avian Flu beneficiary Don Rumsfeld? It is another example of what someone has called the principle of modern US corrupt special interest politics: “Concentrate the benefits; diffuse the costs” President Bush has ordered the US Government to buy $2 billion worth of Gilead Science’s Tamilflu.

This seems not to be the end of the story. British scientists are reportedly genetically engineering chickens to produce birds resistant to the lethal strains of the H5N1 virus devastating poultry in the Far East. Could a fake Avian Flu hype be merely the pretext to control Asian poultry supplies with Genetically Modified products along with rice?

Not long ago, President Bush sought to instill panic in this country by telling us a minimum of 200'000 people will die from the avian flu pandemic, but it could be as bad as 2 million deaths in this alone.

This hoax is then used to justify the immediate purchase of 80 million doses of Tamiflu, a worthless drug that in no way shape or form treats the avian flu, but only decreases the amount of days one is sick and can actually contribute to the virus having more lethal mutations.

So the U.S. placed an order for 20 million doses of this worthless drug at a price of $100 per dose. That comes to a staggering $2 billion.

Michel Chossudovsky, Global Research, 26 Oct 2005
(www.globalresearch.ca/index.php?context=viewArticle&code=%20ME20051026&articleId=1148)

printer friendly version
Article published on 06-11-2005

© 2001-2004. All rights reserved.
No reproduction, copy or transmission of this publication may be made without written permission.

(mails to the webmaster)